Medartis convertible bonds

Medartis Holding AG, headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange under the ticker symbol MED, completed on 11 April 2024 its issuance of CHF 115.8 million convertible bonds which were successfully placed by way of a private placement to professional clients on 4 April 2024 with BofA Securities Europe SA and Zürcher Kantonalbank acting as joint bookrunners. The convertible bonds were issued via Medartis’ French subsidiary Medartis International Finance SAS with the payment obligations guaranteed by the parent company. The net proceeds will be used for general funding purposes including acquisitions in Medartis’ core business.

Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. Medartis employs approx. 830 individuals across its 13 locations, with products offered in over 50 countries globally.

Lenz & Staehelin acted as legal counsel to Medartis. The team included Patrick Schleiffer, Patrick Schärli, Martina Pavicic and Lillian Rüttimann (all Capital Markets/Corporate).